LVM Capital Management Ltd. MI Has $1.45 Million Position in Medtronic plc (NYSE:MDT)

LVM Capital Management Ltd. MI reduced its holdings in Medtronic plc (NYSE:MDT - Free Report) by 43.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 18,103 shares of the medical technology company's stock after selling 13,838 shares during the quarter. LVM Capital Management Ltd. MI's holdings in Medtronic were worth $1,446,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in MDT. Fortitude Family Office LLC acquired a new position in shares of Medtronic during the third quarter worth approximately $27,000. Highline Wealth Partners LLC bought a new position in Medtronic during the third quarter worth $27,000. Darwin Wealth Management LLC acquired a new position in Medtronic during the 3rd quarter valued at $27,000. J. Stern & Co. LLP acquired a new position in Medtronic during the 3rd quarter valued at $30,000. Finally, Chelsea Counsel Co. bought a new stake in Medtronic in the 3rd quarter valued at $45,000. 82.06% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Sanford C. Bernstein upped their price objective on shares of Medtronic from $96.00 to $97.00 and gave the company an "outperform" rating in a research report on Wednesday, November 20th. Evercore ISI upped their price target on Medtronic from $100.00 to $104.00 and gave the company an "outperform" rating in a report on Tuesday, October 1st. Robert W. Baird decreased their price objective on Medtronic from $96.00 to $93.00 and set a "neutral" rating on the stock in a report on Wednesday, November 20th. Barclays upped their target price on Medtronic from $105.00 to $109.00 and gave the company an "overweight" rating in a research note on Tuesday, November 26th. Finally, Royal Bank of Canada upgraded shares of Medtronic from a "sector perform" rating to an "outperform" rating and lifted their price target for the stock from $98.00 to $105.00 in a research note on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Medtronic presently has an average rating of "Hold" and an average target price of $95.00.

Medtronic Price Performance

NYSE MDT traded down $2.06 during trading hours on Friday, reaching $80.62. 7,067,217 shares of the company's stock were exchanged, compared to its average volume of 7,406,823. The firm has a fifty day moving average of $83.99 and a 200-day moving average of $84.88. The company has a current ratio of 1.84, a quick ratio of 1.39 and a debt-to-equity ratio of 0.51. Medtronic plc has a one year low of $75.96 and a one year high of $92.68. The stock has a market cap of $103.38 billion, a PE ratio of 24.65, a price-to-earnings-growth ratio of 2.33 and a beta of 0.83.

Medtronic (NYSE:MDT - Get Free Report) last issued its quarterly earnings results on Tuesday, November 19th. The medical technology company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.25 by $0.01. Medtronic had a net margin of 13.00% and a return on equity of 13.79%. The business had revenue of $8.40 billion for the quarter, compared to the consensus estimate of $8.27 billion. During the same quarter in the prior year, the company earned $1.25 EPS. The firm's quarterly revenue was up 5.2% on a year-over-year basis. On average, equities research analysts predict that Medtronic plc will post 5.45 earnings per share for the current fiscal year.

Medtronic Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be paid a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 3.47%. The ex-dividend date of this dividend is Friday, December 27th. Medtronic's dividend payout ratio (DPR) is presently 85.63%.

Insider Activity at Medtronic

In other Medtronic news, EVP Brett A. Wall sold 9,850 shares of Medtronic stock in a transaction on Wednesday, January 8th. The shares were sold at an average price of $80.41, for a total transaction of $792,038.50. Following the completion of the sale, the executive vice president now owns 40,708 shares of the company's stock, valued at approximately $3,273,330.28. The trade was a 19.48 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.20% of the stock is owned by company insiders.

Medtronic Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.